EIC Accelerator

EIC Accelerator provides substantial financial support to SMEs, and start-ups to scale up high impact innovations with the potential to create new markets or disrupt existing ones. The EIC Accelerator is offered in two forms: grant only (up to €2.5M) or blended finance that combines grant and investment funding (up to €2.5M grant + €10M equity).

Applying for the EIC Accelerator should be considered if your company:

has developed a novel technological solution that is building on scientific discovery or technological breakthroughs (deep tech) and has clear competitive edge
is tackling an industry-wide bottleneck that cannot be solved efficiently with existing technologies
has already demonstrated prototype solution in operational environment (TRL6)
can prove strong market demand for the solution

If you ticked all the boxes, then this is an opportunity for you. The funding supports the later stages of technology development as well as scale up.

quick facts

Single-applicant
€0.5 - 2.5 million grant
€0.5 - 10 million equity

Blended finance

Funding: grant up to €2.5M + equity investment between €1M to €10M

Grant-funded product development project (TRL 6/7 -> TRL8) can include later stage technology development activities, customer piloting, preparations for sales and scale-up. The grant covers 70% of the project costs.

Commercialization and scale-up activities (TRL 9) are funded with an investment component that can be requested in parallel to the grant or at a later stage during the lifetime of the grant agreement. The EIC investment is meant for catalyzing a larger overall funding round with private co-investors.

Grant only

Funding: up to €2.5M grant

Product development project (TRL 6/7 -> TRL8) can include later stage technology development activities, customer piloting, preparations for sales and scale-up. The grant covers 70% of the project costs.

Companies applying for only the grant component need to demonstrate access to resources needed to commercialize and scale-up the innovation without EIC equity support.

Our services

Our consultants will guide you throughout the whole project preparation process and be responsible for compiling a competitive proposal. This includes activities such as:

Project idea formulation
Structuring the work plan
Project budgeting
Market research and business plan compilation
Overall project management and administrative tasks

managing partner

Silver Toomla

Mobile: +372 5171 781
E-mail: silver.toomla@invent.ee

Our success stories

€1.63 million

Consultants of Invent Baltics supported Keel24 and Sentab in preparing successful project proposals to Horizon 2020 SME Instrument Phase 2 funding programme. Keel24 and Sentab are the first Estonian firms that have been successful in the Phase 2 projects as coordinators.

€1.71 million

Invent Baltics consultants helped the Finnish company Paumax Oy /AINA Wireless, dedicated to developing innovative IP-based communication solutions, to prepare a successful project proposal to the European Commission Horizon 2020 research and innovation funding program.

€2.2 million

Invent Baltics consultants supported Finnish company Paptic Oy in preparing a successful SME Instrument Phase 2 project proposal to the European Commission Horizon 2020 research and innovation funding program.

€2 million

ZenRobotics Oy, a Finnish company, received €2 Million funding from the Horizon 2020 SME Instrument Phase 2, for developing its next generation robotic waste sorting system. The new generation utilizes advanced multi-sensor systems and machine learning technology for sorting commercial and industrial waste.

€1.81 million

€1.04 million

Invent Baltics helped the Finnish company Uniq Bioresearch, active in developing a novel microencapsulation technology, to compose a successful project proposal to the European Commission Horizon 2020 research and innovation funding program.

€1 million

Invent Baltics helped Finnish company Bionova Oy to prepare a successful project proposal to the Horizon 2020 Research and Innovation funding programme.

€1.1 million

Invent Baltics helped UK company Monese Ltd to prepare a successful project proposal to the Horizon 2020 Research and Innovation funding programme.

€1.2 million

Icosagen Cell Factory, a spin-off company from the University of Tartu, received a prestigious SME grant within the framework of Horizon 2020, the EU Framework Programme for Research and Innovation, in which the European Commission hand-picks businesses to invest in and support.

€1.6 million

Invent Baltics assisted Advanced Sports Installations Europe AS (ASIE) in putting together successful project application for Horizon 2020 SME-Instrument. In cooperation with Invent Baltics, ASIE had previously completed SME-Instrument Phase 1 (50,000 € grant) for conducting comprehensive feasibility study, including freedom-to-operate analysis and market studies.

€840.000

Invent Baltics consultants supported Finnish company Alleco Oy in preparing a successful SME Instrument Phase 2 project proposal to the European Commission Horizon 2020 research and innovation funding program. The project with a total budget of €1.2 million was the highest scoring proposal under the Open Disruptive Innovation (ICT) topic.

€1.2 million

Invent Baltics consultants supported Finnish company Remote A Oy in preparing a successful SME Instrument Phase 2 project proposal. The project with a total budget of €1,7 million will receive support under the Horizon 2020 topic “Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well“.

€2.2 million

Invent Baltics consultants supported the Finnish company Brighterwave Oy in preparing a successful SME Instrument Phase 2 project proposal to the European Commission Horizon 2020 research and innovation funding program.

€1.6 million

Invent Baltics consultants supported Finnish company Cloudstreet Oy in preparing a successful SME Instrument Phase 2 project proposal. The project with a total budget of €2.3 million will receive support under the Open Disruptive Innovation Scheme.

€1.7 million

Invent Baltics consultants supported Finnish company Minima Processor Oy in preparing a successful SME Instrument Phase 2 project proposal. The project with a total budget of €2,4 million will receive support under the Horizon 2020 topic “Information and Communication Technologies“.

€2.8 million

Consultants at Invent Baltics supported Estonian company Optofluid Technologies OÜ (OFT) in preparing a successful SME Instrument Phase 2 project proposal. The project will receive a grant of €2.8 million under the Horizon 2020 topic “Personalized Health and Care“.

€1.3 million

Invent Baltics consultants supported Estonian company MikroMasch Eesti OÜ in preparing a successful SME Instrument Phase 2 project proposal. The project with a total budget of €1,8 million will receive support under the Horizon 2020 topic “Secure, Clean and Efficient Energy“.

€2.4 million

Invent Baltics consultants supported Finnish company Spectral Engines Oy in preparing a successful SME Instrument Phase 2 project proposal. The project with a total budget of €3,3 million will receive support under the Horizon 2020 topic “Open Disruptive Innovation Scheme“.

€1.75 million

Invent Baltics consultants supported Finnish company Nukute Oy in preparing a successful SME Instrument Phase 2 project proposal. The project with a total budget of €2,5 million will receive support under the Horizon 2020 topic “Open Disruptive Innovation Scheme“.

€1.28 million

Invent Baltics consultants supported Cybernetica AS in preparing a successful SME Instrument Phase 2 project proposal. The project with a total budget of €1,83 million will receive support under the Horizon 2020 topic “Open Disruptive Innovation Scheme“.

€1.7 million

Invent Baltics consultants supported Irish company Axonista in preparing a successful SME Instrument Phase 2 project proposal. The project with a total budget of €2,4 million will receive support under the Horizon 2020 topic “Open Disruptive Innovation Scheme“.

€1.56 million

Filtra Group has developed an innovative industrial dust extraction technology that complies with the current air quality regulations and enables 80% cost-cutting compared to technology used at industrial plants at the moment

€2.37 million

Varjo Technologies Oy is the first company in the world to build a VR/AR/MR headset capable of human eye resolution.

€1.95 million

Iristick develops innovative assisted reality enhanced eyewear for industrial applications. The smart glasses feel just like regular glasses: comfortable, light, balanced and stable

€1.95 million

Grundium has created a disruptive technology that enables to launch the world´s first portable and low-cost digital scanning microscope for clinical and research use.

€1.61 million

Virtual Solutions has developed software that makes robotic process automation accessible for the mass market.

€1.45 million

1oT has developed an IoT connectivity platform that allows IoT device makers to get global data coverage for all of their devices. The truly universal platform is able to serve more than 95% of IoT device makers that need wide-area coverage and reduce their data cost up to 50%.

€1.36 million

720° is a unique sensor-based solution that improves the productivity and well-being of office workers by analysing Indoor Environmental Quality (IEQ) in real time and automatically taking measures to ensure optimised working conditions. It helps its customers to turn office buildings into an employee productivity management tool.

€1.93 million

Sulapac has created the most sustainable packaging solution in the world. It is 100% biodegradable and contains 0% microplastics. Sulapac® has all the benefits of plastic, but without the waste problem. The renewable wood-based material has a low carbon footprint, yet it is similar to plastic in terms of price, formability and functionality

€2.5 million

BioMensio multi-drug testing platform is the first palm-sized and highly accurate device to detect drug intoxication from saliva. The patented bio-sensing technology enables to simultaneously measure a person’s intoxication from virtually any widely used narcotics, in an easy-to-administrate test that provides results in just 1-2 minutes.

€1.9 million

Global EcoProcess Services Oy (EPSE) has developed, patented and tested a simple new technology that enables to remove metals from industrial wastewater completely. After the process only purified water and solid metals are remaining. Both are reusable in manufacturing as valuable raw materials.

€1.95 million

Infinited Fiber Company (IFC) has developed low-cost process for producing cellulose based fiber from textiles waste. The fiber product – called Infinited Fiber – is sustainable, affordable, and available in unlimited quantities. Unlike viscose and polyester, Infinited Fiber has the touch and feel of cotton, which is preferred by consumers. It is the only fiber that meets the industry needs

€2.5 million

FocalSpec revolutionary 3D imaging sensors offer laboratory level measurement accuracy for detecting microscopic imperfections on battery electrodes at the speed of manufacturing lines (moving 3 meters persecond). The technology enables carrying out submicron-level analysis ofshapes, profiles, textures, thicknesses, dimensions, roughness, etc. No otherindustrial measurement solution, including laser, is able to combine such speed and precision.

€2.2 million

Biomendex Oy has developed a revolutionary synthetic bone graft substitute for bone regeneration. The invention, Adaptos™ is the first bioactive bone graft substitute that surgeons can cut, shape or squeeze into place, while eliminating bone harvesting in patients. Biomendex is changing the way bone voids are treated, by providing the bone graft substitutes that lead to better surgical outcomes, reduced operation time and risks, as well as lead to financial savings.

€2.1 million

Aiforia Technologies Oy has developed the he Aiforia® Platform that brings together image-based AI and high-performance cloud computing, optimized for enormous images in the field of digital pathology. The platform improves the efficiency and consistency of pathologists’ clinical sample analysis by automating the current slow and manual analysis. As a result, diagnistics accuracy will be greatly enhanced.

€3.9 million

Neuro Event Labs Oy is developing an epilepsy diagnostics tool that enables selecting the most efficient treatment plan for each patient. Although epilepsy treatment is efficient and widely available, drug therapy is inefficient for 30% of patients because of the lack of objective data about seizures of each patient. Using state-of-the-art machine intelligence and 3D computer vision, Neuro Event Labs provides the missing data required for treating all seizure patients.

€1.9 million

Sooma Oy is a pioneering Finnish medical technology SME with a mission to bring relief to the millions of people who suffer from depression. It has developed a non-invasive brain stimulation tool that has proven highly effective and safe for treating severe depression. This can help over 300 million people that suffer from depression worldwide.

€2.5 million

Woodio is a Finnish interior and design company that is a leader in sustainable bio-materials. Woodio’s signature material is the world’s first 100% waterproof solid wood composite designed for bathrooms – with a minimal carbon footprint. With the novel material, Woodio aims to reduce the massive CO2 emissions from the ceramics industry.

€3 million

Ampher is a smart charging company on a mission to support EU on the monumental shift from internal combustion engines to electric vehicles. It has developed a unique technology that allows to utilize the full grid capacity when charging EVs. Thanks to this innovation, there is no need to invest billions into building new grid capacity.

€10.5 million

Glucomodicum is pioneering a revolutionary new sensor, the Talisman, which measures glucose molecules diffused through your skin. This is based on unique platform magnetohydrodynamic technology that can sample interstitial fluid, the body fluid between blood vessels and cells, non-invasively, rapidly and gently. This is the first time in 25 years that a new technology category has been introduced in this space.

€7.5 million

Minima Processors enables to improve the energy efficiency of digital processors. With their patented Minima Dynamic Marginig technology they can lower the energy consumption of any digital device by 60%.

€2.5 million

Askel Healthcare brings the best solution to heal cartilage. Their COPLA® product is tailored to adapt to the specific conditions of weight-bearing joints to fully heal cartilage for pain-free movement. It could postpone or even prevent undergoing total joint replacement surgery, thus offering great benefits for a vast number of patients.

€2.5 million

BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy. Their technology offers any EV longer lifetime, increased range and lower costs.

€1.9 million

Patchstack helps to protect websites from open-source code vulnerabilities. Their technology is the first truly scalable solution for protecting the wide variety of plugins used extensively in modern websites.

€2.5 million

Paptic revolutionizes environmental new material, wood-based renewable and recyclable products replacing paper and plastic. Paptic Foam is a new material for flexible packaging, combining the sustainability of paper, versatility of plastics and haptics of textiles. The unique haptic properties also enable consumers to differentiate the products, improving efficiency of sustainability communication of end-users/brand owners. Paptic’s patented material technology has vast application opportunities in various flexible packaging market segments like dry and frozen food packaging, electronics, hygienic products, toys, etc. Paptic technology enables resource efficient manufacturing and higher product performance, making Paptic the most sustainable alternative to plastics.

€2.5 million

Peili Vision has developed a virtual reality platform for diagnosing and treating neurological disorders that is accurate, scalable and affordable. Based on gamification and artificial intelligence, Peili provides full care path for patients at the comfort of their home: 1) accurate diagnostics based on the latest neurology research data; 2) fully-immersive and personalised rehabilitation exercises based on diagnostics results; and 3) remote treatment and medication efficacy evaluation for best treatment outcomes.

€2.4 million

Surgify Medical Oy is a medical device start-up from Finland, established in May 2017 as a spin-off from Aalto University. Surgify has developed an innovative Safety Burr that enables surgeons to cut bone accurately and efficiently without compromising the safety of important soft structures. The technology eliminates the risk of soft tissue injuries (nerve damages, infections and internal bleeding), meaning faster patient recovery with reduced overall healthcare costs up to €2.7 million for the hospitals. Thanks to the scalable technology, the safety feature can be customized for wide range of applications e.g. orthopaedics, pediatrics and robotics-assisted surgery.

€2 million

Nanordica Medical is an Estonian deep tech company. They are pioneers in advanced antibacterial nanotechnology preventing and curing topical bacterial infections. The developed solution aims to reduce severe complications from wound infections such as amputations and prolong the life expectancy and quality of life of the patients. The wound dressing is applicable for different wound types such as ulcers, burns but also suitable for prophylactic use. The underlying antibacterial technology is highly multifunctional and can be used in different product types such as ointments or creams.

€2.5 million

Skyfora focuses on weather intelligence research and solutions that allow weather data to be collected more accurately. During the EIC project Skyfora is developing a ground-breaking innovation that is the first to provide accurate and detailed weather information in 3D derived from GNSS signal delay data. This technology enables real-time measurement of the most important weather parameters around the globe, instead of certain measured locations. As a result, the threats of extreme weather phenomena (storms, floods, snowstorms, heatwaves etc) can be continuously monitored and timely measures can be taken to save lives and mitigate economic disruptions and financial risks.

€2.5 million

PiBond is one of two companies globally who have innovated inorganic EUVL materials meeting the of the demands of semiconductor industry. PiBond is developing silicon-based photoresist materials that simplify integrated circuit (IC) production by decreasing the need for repetition and materials needed in IC chip manufacturing. This enables high resolution patterning in the most advanced nodes where conventional materials can no longer meet the industry requirements. In addition, this translates to significant savings in manufacturing time and consumed chemicals, driving down the cost of ownership by more than 10M euros per fabrication plant on an annual basis.

€2.5 million

CurifyLabs is a Finnish HealthTech company creating 3D printing solutions for personalized medicine. By modernizing the drug compounding process in pharmacies, CurifyLabs enables sustainable, quality-controlled production of personalized medicine, customized to provide safe and effective treatment for all patients. The MiniLab will offer everything a pharmacy needs for successful 3D printing of drugs close to the patients: Patented pre-manufactured pharmaceutical inks that make active pharmaceutical ingredients (APIs) printer-compatible; pharma compliant low-cost 3D printer; and user friendly software for guidance and digital reporting.

€2.5 million

Better Medicine is an Estonian HealthTech startup co-founded by Estonian and Ukrainian researchers. Better Medicine is developing the first AI-powered tool for radiologists that takes the full-body approach and enables dynamic assessment of tumours, overcoming the biggest shortcomings of current offerings on the market. With Better Medicine Artificial Intelligence, the time radiologists spend on interpreting cancer-related CT scans is reduced by 40-60% by automating a range of repetitive tasks to significantly streamline workflows. Ultimately, Better Medicine helps reduce the shortage of radiologists, while saving lives with timely and accurate diagnostics.